Vaccination with Dukoral^® against travelers’ diarrhea (ETEC) and cholera

References

• Steffen R, Castelli F, Nothdurft HD, Rombo L, Zuckerman JN. Vaccination against enterotoxigenic Escherichia coli, a cause of travelers’ diarrhea. J. Travel Med.12, 102–107 (2005).
   PubMed Web of Science ®Google Scholar
• De Bruyn G, Hahn S, Borwick A. Anibiotic treatment for travelers’ diarrhea. Cochrane Database Syst. Rev.3, CD002242 (2000).
   Google Scholar
• Kaper JB, Morris LG Jr, Levine MM. Cholera. Clin. Microbiol. Rev.8, 48–86 (1995).
   PubMed Web of Science ®Google Scholar
• Clemens JD, Pinkelstein RA. Demonstration of shared and unique immunological determinants in enterotoxins from Vibrio cholerae and Escherichia coli. Infect. Immun.22, 709–713 (1978).
   PubMed Web of Science ®Google Scholar
• Moseley SL, Falkow S. Nucleotide sequence homology between the heat-labile enterotoxin gene of Escherichia coli and Vibrio cholerae deoxyribonucleic acid. J. Bacteriol.144, 444–446 (1980).
   PubMed Web of Science ®Google Scholar
• Pierce NF. Protection against challenge with Escherichia coli heat-labile enterotoxin by immunization of rats with cholera toxin/toxoid. Infect. Immun.18, 338–341 (1977).
   PubMed Web of Science ®Google Scholar
• Wittlinger F, Steffen R, Watanabe H, Handszuh H. Risk of cholera among Western and Japanese travelers. J. Travel Med.2(3), 154–158 (1995).
   PubMedGoogle Scholar
• Steffen R, Acar J, Walker E et al. Cholera: assessing the risk to travelers and identifying methods of protection. Travel Med. Infect. Dis.1, 80–88 (2003).
   PubMedGoogle Scholar
• No authors listed. Cholera 2006. Wkly Epidemiol. Rec.82, 273–284 (2008).
   Google Scholar
• Sanchez JL, Taylor DN. Cholera. Lancet349, 1825–1830 (1997).
   PubMed Web of Science ®Google Scholar
• Taylor DN, Rizzo J, Meza R, Perez J, Watts D. Cholera among Americans living in Peru. Clin. Infect. Dis.22, 1108–1109 (1996).
   PubMed Web of Science ®Google Scholar
• Ryan ET, Calderwood SB. Cholera vaccines. J. Travel Med.2, 82–91 (1994).
   Google Scholar
• Cali G. The Italian Army Medical Corps in the United Nations “peace-keeping” operations: Somalia and Mozambique, December 1992–December 1994. Med. Trop. (Mars)56, 400–403 (1996).
   PubMedGoogle Scholar
• Haberberger RL, Mikhail IA, Burans JP et al. Travelers’ diarrhea among United States military personnel during joint American–Egyptian armed forces exercises in Cairo, Egypt. Mil. Med.156, 27–30 (1991).
   PubMed Web of Science ®Google Scholar
• Orndorff GR, Lebron C. Epidemiology of enterotoxigenic Escherichia coli-associated diarrheal disease occurring on board U.S. Navy ships visiting Asian ports. Mil. Med.161, 475–478 (1996).
   PubMed Web of Science ®Google Scholar
• Oyofo BA, Peruski LF, Ismailmt TF et al. Enteropathogens associated with diarrhea among military personnel during Operation Bright Star 96, in Alexandria, Egypt. Mil. Med.162, 396–400 (1996).
   Web of Science ®Google Scholar
• Wolf MK, Taylor DN, Boedecker EC et al. Characteriziation of enterotoxigenic Escherichia coli isolated from U.S. troops deployed to the Middle East. J. Clin. Microbiol.31, 851–856 (1993).
   PubMed Web of Science ®Google Scholar
• Taylor DN, Houston R, Shlim DR et al. Etiology of diarrhea among travelers and foreign residents in Nepal. JAMA260, 1245–1248 (1988).
   PubMed Web of Science ®Google Scholar
• Gascon J, Vargas M, Quinto L et al. Enteroaggregative Escherichia coli strains as a cause of travelers’ diarrhea: a case–control study. J. Infect. Dis.177, 1409–1412 (1998).
   PubMed Web of Science ®Google Scholar
• Gorbach SL, Edelman R. Travelers’ diarrhea National Institutes of Health Consensus Development Conference. Rev. Infect. Dis.8(Suppl. 2), S109–S110 (1986).
   PubMedGoogle Scholar
• Schultz C, van den Ende J, Cobelens F et al. Diarrheagenic Escherichia coli and acute and persistent diarrhea in returned travelers. J. Clin. Microbiol.38, 3550–3554 (2000).
   PubMed Web of Science ®Google Scholar
• Svenungsson B, Lagergren A, Ekwall E et al. Enteropathogens in adult patients with diarrhea and healthy control subjects: a 1-year prospective study in a Swedish clinic for infectious diseases. Clin. Infect. Dis.30, 770–778 (2000).
   PubMed Web of Science ®Google Scholar
• Chapman PA, Mitchelmore DA. A two-year survey of the incidence of heat-labile enterotoxin-producing Escherichia coli and other enteric pathogens in travelers returning to the Sheffield area. Epidemiol. Infect.101, 239–247 (1988).
   PubMed Web of Science ®Google Scholar
• Jertborn M, Svennerholm AM, Holmgren J. Safety and immunogenicity of an oral recombinant cholera B subunit–whole cell vaccine in Swedish volunteers. Vaccine10, 130–132 (1992).
   PubMed Web of Science ®Google Scholar
• Sanchez JL, Trofa AF, Taylor DN et al. Safety and immunogenicity of the oral, whole cell/recombinant B subunit cholera vaccine in North American volunteers. J. Infect. Dis.167, 1446–1449 (1993).
   PubMed Web of Science ®Google Scholar
• Clemens JD, Sack DA, Harris JR et al. Field trial of oral cholera vaccines in Bangladesh: results from a three-year follow-up. Lancet14, 162–166 (1986).
   Google Scholar
• Sanchez JL, Vasquez B, Begue RE et al. Protective efficacy of oral whole-cell/recombinant–B-subunit cholera vaccine in Peruvian military recruits. Lancet344, 1273–1276 (1994).
   PubMed Web of Science ®Google Scholar
• Lucas ME, Deen JL, von Seidlein L et al. Effectiveness of mass oral vaccination in Beira, Mozambique. N. Engl. J. Med.352, 757–767 (2005).
   PubMed Web of Science ®Google Scholar
• Scerpella EG, Sanchez JL, Methewson JJ 3rd et al. Safety, immunogenicity, and protective efficacy of the whole-cell/recombinant B subunit (WC/rBS) oral cholera vaccine against travelers’ diarrhea. J. Travel Med.2, 22–27 (1995).
   PubMedGoogle Scholar
• Clemens JD, Sack DA, Harris JR et al. Cross-protection by B subunit–whole cell cholera vaccine against diarrhea associated with heat-labile toxin-producing enterotoxigenic Escherichia coli: results of a large-scale field trial. J. Infect. Dis.158, 1285–1289 (1988).
   Google Scholar
• Peltola H, Siitonen A, Kyronseppa H et al. Prevention of travelers’ diarrhea by oral B-subunit/whole-cell cholera vaccine. Lancet338, 1285–1289 (1991).
   PubMed Web of Science ®Google Scholar
• Lopez-Gigosos R, Garcia-Fortea P, Reina-Doña E, Plaza-Martin E. Effectiveness in prevention of travelers’ diarrhea by an oral cholera vaccine WC/rBS. Travel Med. Infect. Dis.5, 380–384 (2007).
   PubMedGoogle Scholar
• Hill DR, Ford L, Lalloo DG. Oral cholera vaccines: use in clinical practice. Lancet Infect. Dis.6, 361–373 (2006).
   PubMed Web of Science ®Google Scholar
• Zuckerman JN, Rombo L, Fisch A. The true burden and risk of 8cholera: implications for prevention and control. Lancet Infect. Dis.7, 521–530 (2007).
   PubMed Web of Science ®Google Scholar
• Parment PA. Cholera should be considered as a risk for travelers returning to industrialized countries. Travel Med. Infect. Dis.3, 161–163 (2005).
   PubMedGoogle Scholar
• Weinke T, Liebold I, Burchard GD et al. [Prophylactic immunization against enterotoxin-forming Escherichia coli travellers’ diarrhea and cholera: does it make sense and for whom?] Dtsch. Med. Wochenschr.131, 1660–1664 (2006).
   PubMed Web of Science ®Google Scholar
• Sack DA, Shimko J, Torres O et al. Randomised, double-blind, safety and efficacy of a killed oral vaccine for enterotoxigenic E. coli diarrhea of travelers to Guatemala and Mexico. Vaccine25, 4392–4400 (2005).
   Web of Science ®Google Scholar
• Toovey S. The vaccine really does work. Effectiveness of mass cholera vaccination in Beira, Mozambique. Travel Med. Infect. Dis.4, 298–299 (2006).
   Google Scholar
• Topps MH. Oral cholera vaccine – for whom, when, and why? Travel Med. Infect. Dis.4, 38–42 (2006).
   PubMedGoogle Scholar
• Longini IM Jr, Nizam A, Ali M et al. Controlling endemic cholera with oral vaccines. PLoS Med.4, E336 (2007).
   PubMed Web of Science ®Google Scholar
• Ramon Torrell JM, Masuet Aumatell C, Morchon Ramos S et al. Prevention of travelers’ diarrhea among high risk travelers by Dukoral oral vaccination. Presented at: 10th Conference of the International Society of Travel Medicine. Vancouver, Canada, 20–24 May 2007.
   Google Scholar